The single most important rule in antibody clone selection is to choose a clone that has been validated for your exact application, species and sample type, not merely for the target protein in general. We built our sourcing service around this principle, helping researchers compare clones against documented evidence before they order. The sections below set out how to verify that evidence and confirm it on your own bench.
TL;DR:
- Western blots need evidence from denatured samples, while flow cytometry and immunoprecipitation require native state binding; validation does not transfer between these assay types.
- Compare two to five candidates, favor genetic controls over a single stained image, and inspect uncropped results, tested dilutions, sample types, and lot numbers.
- Test candidates with positive, negative, isotype, and secondary only controls; titrate conditions rather than copying supplier dilutions, and include genetic controls in the same experiment.
- Request the clone identifier, RRID, lot number, raw validation images, and tested protocol; these details support exact reordering and help investigate shifting results.
- For projects spanning years, favor recombinant antibodies when sequence availability and lot continuity are confirmed, since defined sequences reduce variation between production batches.
Table of Contents
- Practical checklist for choosing the right clone
- Application-specific considerations across common assays
- A pragmatic in-lab validation workflow
- What to request from suppliers and how to document provenance
- Author perspective: applying these steps in real research
- How ABMIUM can help with antibody clone selection and validation
- FAQ
- Sources
Practical checklist for choosing the right clone
Before testing anything, we filter candidate clones against a short set of criteria that separates well-documented reagents from poorly characterised ones.
- Confirm the clone identifier (clone number or name) and the reagent type (monoclonal, polyclonal or recombinant), and check whether a Research Resource ID is listed, since unambiguous identification is one of the basic rules of antibody validation.
- Require evidence validated specifically for your intended application and confirmed reactivity in your species of interest, not a generic “validated” label.
- Prioritise clones with genetic validation, such as knockout or knockdown controls, or other orthogonal evidence over those supported only by a single stained image.
- Review the full datasheet: raw unedited images, exact dilutions, lot numbers and whatever protocol detail the supplier is willing to share.
- For projects running beyond a single study, favour recombinant antibodies or thoroughly documented monoclonals, since reviews on western blot validation recommend recombinant formats to reduce batch-to-batch variation.
- Shortlist two to five candidates rather than committing to one, so that a disappointing result does not stall the project.
Pro Tip: Keep a simple spreadsheet of candidate clones with their catalogue numbers, RRIDs and validation claims side by side, it makes the in-lab comparison in the next step far quicker.
Application-specific considerations across common assays
Validation is not transferable between techniques. A clone that performs well in one context can behave very differently in another, because the epitope it recognises may only be accessible under certain conditions.
- Western blot requires validation on a linear, denatured epitope, so look for full uncropped blots, the expected molecular weight and the sample types the supplier actually tested.
- Immunofluorescence and immunohistochemistry demand data on fixation and permeabilisation compatibility, ideally with images from tissues or cell types similar to yours.
- Flow cytometry needs validation on native, folded epitopes, together with conjugate performance data and titration against known positive and negative populations.
- Immunoprecipitation requires strong native-state binding, usually confirmed by mass spectrometry or a western blot of the eluate.
Antibodies validated under denatured conditions frequently fail in native-state assays, and a Nature Protocols consensus workflow built around knockout controls is one way the field is standardising comparisons across applications. This single point explains most of the disappointing results researchers report after assuming that “validated” covers every technique.
A pragmatic in-lab validation workflow
Supplier evidence narrows the field, but confirming a clone on your own samples remains the only way to be confident it will behave as expected in your hands.
- Set up positive, negative, isotype and secondary-only controls before running any experimental samples, and include a genetic control (knockout or knockdown) where one is available.
- Titrate the antibody across a concentration range and optimise blocking and incubation conditions rather than defaulting to the datasheet dilution.
- Run at least one orthogonal test, such as a knockout comparison, peptide competition, a second independent antibody against the same target, or mass spectrometry confirmation.
- Where practical, test two separate lots, replicate the key experiment and record every condition used.
- Log raw validation data, assign or record the RRID, and keep full metadata in your lab notebook for future reference.
This sequence mirrors the practical pathway described in community discussions of YCharOS validation protocols, which stress that researchers carry responsibility for in-house validation rather than relying solely on supplier claims. Our specificity testing checklist walks through this same sequence step by step for labs setting it up for the first time.
Pro Tip: Run your genetic or orthogonal control in the same experiment as your candidate clones wherever possible, comparing results from separate runs introduces variability that can obscure a genuine specificity problem.
What to request from suppliers and how to document provenance
Strong provenance starts with asking suppliers for specific, checkable information rather than accepting a generic product description.
- Catalogue number, clone name or number, lot or batch number, RRID, and the preparation method (monoclonal, polyclonal or recombinant).
- Raw validation images, the exact protocol used, the source of the samples tested, and the dilutions applied, plus whether any genetic validation was performed.
- For conjugated reagents, confirmation of the fluorophore or enzyme identity, the degree of labelling and any noted compatibility issues.
- For recombinant antibodies, confirmation that the sequence is on file and that lot continuity is guaranteed, which matters for any study expected to run for years.
Open-access antibody validation guidance lists comparable datasheet items, including immunogen, validation strategy and controls used, as the baseline a vendor should provide.
| Metadata item | Why it matters |
|---|---|
| Catalogue number and clone ID | Enables exact reordering and cross-study comparison |
| RRID | Links the antibody to a persistent, citable record |
| Lot number | Flags batch-to-batch variation if results shift |
| Validation images and protocol | Allows independent assessment of specificity |
Author perspective: applying these steps in real research
In practice, the biggest time loss in clone selection comes from treating a supplier’s “validated” claim as equivalent across every application. We see labs repeatedly order a clone that performed well in immunohistochemistry, then struggle for weeks when it fails to immunoprecipitate the same target. Our sourcing service exists for exactly this problem: our scientists compare candidate clones against the application, species and sample type a researcher specifies, consolidating provenance and validation evidence that would otherwise take days to gather from scattered datasheets. Engaging such a service, or a product validation service for a reagent already in hand, tends to be most efficient before a critical experiment begins, not after a clone has already failed.
— Veron
How ABMIUM can help with antibody clone selection and validation
Choosing between candidate clones is faster when provenance and validation evidence sit alongside the product listing rather than scattered across separate datasheets. We built our catalogue and sourcing service around that need.
- Browse our primary antibodies collection to filter clones by target, species, host and available validation evidence.
- Use ABMIUM MATCH when you want scientist-led help comparing suitable clones against your exact experimental requirements.
- Ask about our Custom Antibody Service when no existing clone meets your specificity or species needs.
If your application needs verified validation before you commit a project timeline to it, contact the sourcing service and you can get help comparing clones against the evidence that matters for your experiment.
FAQ
What is the single most important factor in antibody clone selection?
Choose a clone validated for your exact application, species and sample type rather than one simply marketed as validated for the target. Validation on a denatured epitope, as used in western blot, does not predict performance in a native-state assay such as flow cytometry or immunoprecipitation.
How many candidate clones should I test before settling on one?
A shortlist of two to five candidates gives enough options without making the screening process unmanageable. Filtering first on datasheet evidence and RRID availability, then testing the remainder with titration and one orthogonal control, is a practical route described in community validation protocol discussions.
Are recombinant antibodies better than traditional monoclonals?
Recombinant antibodies offer a defined sequence that can be regenerated indefinitely, which reviews of western blot validation note reduces the batch-to-batch variation seen with hybridoma-derived monoclonals. They are generally recommended for long-term projects where continuity across years of work matters more than upfront cost.
What should a good antibody datasheet include?
A reliable datasheet lists the catalogue number, clone identifier, lot number, immunogen, validation strategy, controls used and raw images alongside the protocol conditions tested. Guidance summarised in antibody validation reviews treats these items as the minimum needed to assess a clone before purchase.
Can validation in one application be trusted for a different application?
No, validation is application-specific because the epitope a clone recognises may only be accessible under certain conditions, such as native versus denatured protein states. A Nature Protocols consensus workflow using knockout controls illustrates why side-by-side testing across applications is needed rather than assuming one result transfers to another.
Sources
- A consensus platform for antibody characterization | Nature Protocols
- Ten basic rules of antibody validation - PMC